Canada Pension Plan Investment Board raised its stake in Danaher Corporation (NYSE:DHR) by 29.7% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 656,467 shares of the conglomerate’s stock after buying an additional 150,400 shares during the quarter. Canada Pension Plan Investment Board owned 0.09% of Danaher Corporation worth $55,399,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Lee Danner & Bass Inc. lifted its holdings in shares of Danaher Corporation by 0.4% during the first quarter. Lee Danner & Bass Inc. now owns 2,635 shares of the conglomerate’s stock worth $225,000 after buying an additional 10 shares during the last quarter. Norway Savings Bank raised its position in shares of Danaher Corporation by 0.4% during the second quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock valued at $189,000 after buying an additional 10 shares during the last quarter. First Financial Corp IN lifted its stake in shares of Danaher Corporation by 0.8% in the second quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock valued at $230,000 after buying an additional 21 shares during the period. Guardian Life Insurance Co. of America increased its stake in Danaher Corporation by 1.0% during the first quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock valued at $202,000 after acquiring an additional 24 shares during the period. Finally, Assetmark Inc. lifted its position in shares of Danaher Corporation by 0.5% in the 1st quarter. Assetmark Inc. now owns 6,622 shares of the conglomerate’s stock worth $566,000 after acquiring an additional 30 shares during the period. Hedge funds and other institutional investors own 75.68% of the company’s stock.
DHR has been the topic of a number of recent research reports. Goldman Sachs Group, Inc. (The) reaffirmed a “neutral” rating and set a $83.00 price target on shares of Danaher Corporation in a report on Tuesday, September 26th. Wells Fargo & Company began coverage on shares of Danaher Corporation in a research note on Thursday, July 13th. They set a “market perform” rating and a $90.00 price target on the stock. Jefferies Group LLC reissued a “buy” rating and issued a $95.00 target price on shares of Danaher Corporation in a research note on Friday, August 4th. BidaskClub downgraded shares of Danaher Corporation from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Finally, Zacks Investment Research lowered shares of Danaher Corporation from a “buy” rating to a “hold” rating in a report on Thursday, July 27th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $91.98.
TRADEMARK VIOLATION WARNING: This news story was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this news story on another domain, it was illegally copied and republished in violation of U.S. & international trademark and copyright law. The legal version of this news story can be accessed at https://stocknewstimes.com/2017/10/01/canada-pension-plan-investment-board-grows-position-in-danaher-corporation-dhr.html.
In related news, insider William King sold 43,688 shares of the company’s stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $82.86, for a total value of $3,619,987.68. Following the completion of the sale, the insider now directly owns 45,748 shares of the company’s stock, valued at $3,790,679.28. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the stock in a transaction that occurred on Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the transaction, the insider now owns 155,520 shares in the company, valued at $12,718,425.60. The disclosure for this sale can be found here. In the last quarter, insiders sold 71,496 shares of company stock valued at $5,916,223. Company insiders own 12.20% of the company’s stock.
Danaher Corporation (NYSE:DHR) traded up 0.87% during trading on Friday, hitting $85.78. The stock had a trading volume of 2,324,440 shares. Danaher Corporation has a 1-year low of $75.71 and a 1-year high of $88.62. The firm has a 50 day moving average price of $82.99 and a 200-day moving average price of $84.20. The firm has a market capitalization of $59.59 billion, a PE ratio of 27.38 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating analysts’ consensus estimates of $0.97 by $0.02. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. The firm had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. During the same period last year, the firm posted $0.90 earnings per share. Danaher Corporation’s revenue for the quarter was up 6.3% compared to the same quarter last year. On average, equities research analysts expect that Danaher Corporation will post $3.95 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 29th will be given a $0.14 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.56 annualized dividend and a yield of 0.65%. Danaher Corporation’s dividend payout ratio is currently 17.83%.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Ratings for Danaher Corporation Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Danaher Corporation and related companies with MarketBeat.com’s FREE daily email newsletter.